Endoscopy 1999; 31(9): 718-724
DOI: 10.1055/s-1999-153
Original Article
Georg Thieme Verlag Stuttgart ·New York

Meta-Analysis of Antibiotic Prophylaxis in Endoscopic Retrograde Cholangiopancreatography (ERCP)

A. Harris 1 , A. Chong Hen Chan 2 , C. Torres-Viera 1 , R. Hammett 3 , D. Carr-Locke 3
  • 1 Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
  • 2 Harvard School of Public Health, Boston, Massachusetts, USA
  • 3 Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 1999 (online)

Background and Study Aims: Considerable controversy exists regarding the role of antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography (ERCP), in that various studies of antibiotic prophylaxis have reached conflicting conclusions. The aim of this meta-analysis is to synthesize the data in order to determine whether antibiotic prophylaxis reduces the rate of occurrence of bacteremia and/or the rate of sepsis/cholangitis among patients undergoing ERCP.

Patients and Methods: Clinical trials were selected via Medline and Pubmed using subject words and textwords „ERCP”, „antibiotic” and „antibiotic prophylaxis”. Summary estimates of the risk ratios for the outcomes of bacteremia and sepsis/cholangitis were calculated.

Results: After 49 abstracts had been reviewed, seven randomized placebo-controlled trials of antibiotic prophylaxis prior to ERCP were identified. Upon further review, two studies were excluded because patients received antibiotics before and after the ERCP. Four studies reported on the clinical outcome of bacteremia. Five studies reported on the clinical outcome of sepsis/cholangitis. The summary relative risk of the association between antibiotic prophylaxis and bacteremia was 0.39 (95 % CI, 0.12 - 1.29). For sepsis/cholangitis the summary relative risk was 0.91 (95 % CI, 0.39 - 2.15).

Conclusions: Antibiotic prophylaxis prior to ERCP may reduce the incidence of bacteremia but this has little clinical relevance. Prophylaxis does not substantially reduce the incidence of sepsis/cholangitis and thus the routine use of antibiotic prophylaxis cannot be recommended.

References

  • 1 Safrany L. Antibiotic prophylaxis in endoscopy: new round in an old discussion.  Endoscopy. 1991;  23 91-94
  • 2 Kullman E, Borch K, Lindström E, et al. Bacteremia following diagnostic and therapeutic ERCP.  Gastrointest Endosc. 1992;  38 444-449
  • 3 Bilbao M K, Dotter C T, Lee T G, et al. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10 000 cases.  Gastroenterology. 1976;  70 314-320
  • 4 Huibregtse K. Endoscopic biliary and pancreatic drainage. New York; Thieme 1988: 121-123
  • 5 Freeman M, Nelson D, Sherman S, et al. Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
  • 6 Loperfido S, Giampaolo A, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.  Gastrointest Endosc. 1998;  48 1-10
  • 7 Sauter G, Grabein B, Huber G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study.  Endoscopy. 1990;  22 164-167
  • 8 British Society of Gastroenterology. Antibiotic prophylaxis in gastrointestinal endoscopy: A report by a working party for the British Society of Gastroenterology Endoscopy Committee.  Endoscopy. 1997;  29 114-119
  • 9 Rey J R, Axon A, Budzynska A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy.  Endoscopy. 1998;  30 318-324
  • 10 American Society for Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy.  Gastrointest Endosc. 1995;  42 630-635
  • 11 DerSimonian R, Laird N. Meta-analysis in clinical trials.  Controlled Clin Trials. 1986;  7 177-188
  • 12 Niederau C, Polmann U, Lubke H, et al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: Results of a randomized controlled clinical study.  Gastrointest Endosc. 1994;  40 533-537
  • 13 Byl B, Deviere J, Struelens M J, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double blind, placebo-controlled study.  Clin Infect Dis. 1995;  20 1236-1240
  • 14 Finkelstein R, Yassin K, Suissa A, et al. Failure of cefonicid prophylaxis for infectious complications related to endoscopic retrograde cholangiopancreatography.  Clin Infect Dis. 1996;  23 378-379
  • 15 Hazel S J, Speelman P, Dankert J, et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial.  Ann Intern Med. 1996;  125 442-447
  • 16 Lorenz R, Lehn N, Born P, et al. Antibiotic prophylaxis with cefuroxime in therapeutic endoscopy of the bile ducts.  Dtsch med Wochenschr. 1996;  121 223-230
  • 17 Brandes J W, Scheffer B, Lorenz-Meyer H, et al. ERCP: complications and prophylaxis. A controlled study.  Endoscopy. 1981;  13 27-30
  • 18 van der Meer J TM, van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis.  Lancet. 1992;  339 135-139
  • 19 Horstkotte D, Rosin H, Friedrichs W, et al. Contribution for choosing the optimal prophylaxis of bacterial endocarditis.  Eur Heart J. 1987;  8 (Suppl. 1) 379-381
  • 20 Imperiale T F, Horwitz R I. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy.  Am J Med. 1990;  88 131-136
  • 21 Smith B C, Alqamish J R, Watson K J, et al. Preventing endoscopic retrograde cholangiopancreatography related sepsis: a randomized controlled trial comparing two antibiotic regimes.  J Gastroenterol Hepatol. 1996;  11 938-941
  • 22 Mehal W Z, Culshaw K D, Tillotson G S, et al. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.  Eur J Gastroenterol Hepatol. 1995;  7 541-545

A. HarrisM.D. 

Division of Hospital Epidemiology

University of Maryland

10 South Pine Street

Room 934

Baltimore, MD 21201-1595

USA

eMail: aharris@medicine.umaryland.edu